RBD-SpyCatcher-mi3 vaccine construct could be a promising candidate for broad protection against SARS-CoV-2 variants, advocating for further clinical testing.
ProSci’s Custom Antibody Services were used to develop a mouse monoclonal antibody against cGAMP in a recent study.
ProSci has generated several antibody reagents for SARS-CoV-2 research. Two of these antibodies were used in research by Yunguang Sun and colleagues.
Researchers at New York University Grossman School of Medicine, led by Erin E. Congdon, have explored the potential of single-domain antibodies (sdAbs) in treating tauopathies, including Alzheimer’s disease. The results of their study were recently published in The Lancet® and focused
At ProSci, custom polyclonal antibodies are generated in various host species from customised immunogens designed by expert antibody scientists.
ProSci has more than 800 research-grade biosimilar antibodies in their catalogue and a team of custom antibody specialists providing expertise.
ProSci offers a suite of services to develop rabbit recombinant antibodies with a defined structure, providing highly consistent & specific antibodies.
ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.
ProSci Incorporated has been selected as the 2022 Bioz Stars Award Winner in the COVID-19 Category.
ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.